CoChat

Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease

Open access
Cianflone, Eleonora, Torella, Michele, Biamonte, Flavia, De Angelis, Antonella, Urbanek, Konrad, Costanzo, Francesco S., Rota, Marcello, Ellison-Hughes, Georgina M., Torella, Daniele · 2020 · Cells
Cited by 132

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Abstract

Adult stem/progenitor are a small population of cells that reside in tissue-specific niches and possess the potential to differentiate in all cell types of the organ in which they operate. Adult stem cells are implicated with the homeostasis, regeneration, and aging of all tissues. Tissue-specific adult stem cell senescence has emerged as an attractive theory for the decline in mammalian tissue and organ function during aging. Cardiac aging, in particular, manifests as functional tissue degeneration that leads to heart failure. Adult cardiac stem/progenitor cell (CSC) senescence has been accordingly associated with physiological and pathological processes encompassing both non-age and age-related decline in cardiac tissue repair and organ dysfunction and disease. Senescence is a highly active and dynamic cell process with a first classical hallmark represented by its replicative limit, which is the establishment of a stable growth arrest over time that is mainly secondary to DNA damage and reactive oxygen species (ROS) accumulation elicited by different intrinsic stimuli (like metabolism), as well as external stimuli and age. Replicative senescence is mainly executed by telomere shortening, the activation of the p53/p16INK4/Rb molecular pathways, and chromatin remodeling. In addition, senescent cells produce and secrete a complex mixture of molecules, commonly known as the senescence-associated secretory phenotype (SASP), that regulate most of their non-cell-autonomous effects. In this review, we discuss the molecular and cellular mechanisms regulating different characteristics of the senescence phenotype and their consequences for adult CSCs in particular. Because senescent cells contribute to the outcome of a variety of cardiac diseases, including age-related and unrelated cardiac diseases like diabetic cardiomyopathy and anthracycline cardiotoxicity, therapies that target senescent cell clearance are actively being explored. Moreover, the further understanding of the reversibility of the senescence phenotype will help to develop novel rational therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9061558

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 125

  1. Lee, 2019, The dynamic nature of senescence in cancer, Nat. Cell Biol., 21, 94, 10.1038/s41556-018-0249-2 · DOI · Paper page
  2. Cable, 2020, Adult stem cells and regenerative medicine-a symposium report, Ann. N. Y. Acad. Sci., 1462, 27, 10.1111/nyas.14243 · DOI
  3. Pinho, 2019, Haematopoietic stem cell activity and interactions with the niche, Nat. Rev. Mol. Cell Biol., 20, 303, 10.1038/s41580-019-0103-9 · DOI · Paper page
  4. Almada, 2016, Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease, Nat. Rev. Mol. Cell Biol., 17, 267, 10.1038/nrm.2016.7 · DOI · Paper page
  5. Gehart, 2019, Tales from the crypt: New insights into intestinal stem cells, Nat. Rev. Gastroenterol. Hepatol., 16, 19, 10.1038/s41575-018-0081-y · DOI · Paper page
  6. Fuchs, 2018, Skin Stem Cells in Silence, Action, and Cancer, Stem Cell Rep., 10, 1432, 10.1016/j.stemcr.2018.04.008 · DOI
  7. Schultz, 2016, When stem cells grow old: Phenotypes and mechanisms of stem cell aging, Development, 143, 3, 10.1242/dev.130633 · DOI · Paper page
  8. Rudolph, 2019, Quiescence: Good and Bad of Stem Cell Aging, Trends Cell Biol., 29, 672, 10.1016/j.tcb.2019.05.002 · DOI
  9. Gude, 2018, Cardiac ageing: Extrinsic and intrinsic factors in cellular renewal and senescence, Nat. Rev. Cardiol., 15, 523, 10.1038/s41569-018-0061-5 · DOI · Paper page
  10. Gage, 2019, Adult neurogenesis in mammals, Science, 364, 827, 10.1126/science.aav6885 · DOI · Paper page
  11. Kalamakis, 2019, Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain, Cell, 176, 1407, 10.1016/j.cell.2019.01.040 · DOI · Paper page
  12. Torella, 2004, Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression, Circ. Res., 94, 514, 10.1161/01.RES.0000117306.10142.50 · DOI · Paper page
  13. Cianflone, 2019, Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?, Oxid. Med. Cell. Longev., 2019, 5813147, 10.1155/2019/5813147 · DOI
  14. Shimizu, 2019, Cellular senescence in cardiac diseases, J. Cardiol., 74, 313, 10.1016/j.jjcc.2019.05.002 · DOI · Paper page
  15. Robinson, 2017, SnapShot: Cellular Senescence Pathways, Cell, 170, 816, 10.1016/j.cell.2017.07.049 · DOI
  16. Park, 2005, DNA repair defects in stem cell function and aging, Annu. Rev. Med., 56, 495, 10.1146/annurev.med.56.082103.104546 · DOI · Paper page
  17. Sinha, 2014, A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium, Nature, 507, 253, 10.1038/nature12970 · DOI · Paper page
  18. Rando, 2019, Stem Cell Quiescence: Dynamism, Restraint, and Cellular Idling, Cell Stem Cell, 24, 213, 10.1016/j.stem.2019.01.001 · DOI · Paper page
  19. Kanaar, 2008, DNA repair by the MRN complex: Break it to make it, Cell, 135, 14, 10.1016/j.cell.2008.09.027 · DOI
  20. Walter, 2015, Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells, Nature, 520, 549, 10.1038/nature14131 · DOI · Paper page
  21. Wang, 2011, Quantifying the Waddington landscape and biological paths for development and differentiation, Proc. Natl. Acad. Sci. USA, 108, 8257, 10.1073/pnas.1017017108 · DOI · Paper page
  22. Sun, 2014, Structural and mechanistic insights into Mcm2-7 double-hexamer assembly and function, Genes Dev., 28, 2291, 10.1101/gad.242313.114 · DOI
  23. Liu, 2013, A meta-analysis of the genomic and transcriptomic composition of complex life, Cell Cycle, 12, 2061, 10.4161/cc.25134 · DOI · Paper page
  24. Chambers, 2007, Nanog safeguards pluripotency and mediates germline development, Nature, 450, 1230, 10.1038/nature06403 · DOI · Paper page
  25. Kofman, 2013, Transcriptional analysis of histone deacetylase family members reveal similarities between differentiating and aging spermatogonial stem cells, Stem Cell Rev. Rep., 9, 59, 10.1007/s12015-012-9392-5 · DOI
  26. Chen, 2008, Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair, Cell, 134, 231, 10.1016/j.cell.2008.06.035 · DOI · Paper page
  27. Oberdoerffer, 2008, SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging, Cell, 135, 907, 10.1016/j.cell.2008.10.025 · DOI · Paper page
  28. Oakley, 2007, Unraveling the complex regulation of stem cells: Implications for aging and cancer, Leukemia, 21, 612, 10.1038/sj.leu.2404530 · DOI
  29. Boyer, 2006, Polycomb complexes repress developmental regulators in murine embryonic stem cells, Nature, 441, 349, 10.1038/nature04733 · DOI · Paper page
  30. Lee, 2006, Control of developmental regulators by Polycomb in human embryonic stem cells, Cell, 125, 301, 10.1016/j.cell.2006.02.043 · DOI · Paper page
  31. Kamminga, 2006, The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion, Blood, 107, 2170, 10.1182/blood-2005-09-3585 · DOI · Paper page
  32. Lessard, 2003, Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis, Exp. Hematol., 31, 567, 10.1016/S0301-472X(03)00081-X · DOI
  33. Pirrotta, 1998, Polycombing the genome: PcG, trxG, and chromatin silencing, Cell, 93, 333, 10.1016/S0092-8674(00)81162-9 · DOI · Paper page
  34. Ringrose, 2004, Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins, Annu. Rev. Genet., 38, 413, 10.1146/annurev.genet.38.072902.091907 · DOI · Paper page
  35. Kirmizis, 2004, Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27, Genes Dev., 18, 1592, 10.1101/gad.1200204 · DOI · Paper page
  36. Lund, 2004, Polycomb complexes and silencing mechanisms, Curr. Opin. Cell Biol., 16, 239, 10.1016/j.ceb.2004.03.010 · DOI · Paper page
  37. Czermin, 2002, Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites, Cell, 111, 185, 10.1016/S0092-8674(02)00975-3 · DOI · Paper page
  38. Shao, 1999, Stabilization of chromatin structure by PRC1, a Polycomb complex, Cell, 98, 37, 10.1016/S0092-8674(00)80604-2 · DOI · Paper page
  39. Lessard, 1998, Stage-specific expression of polycomb group genes in human bone marrow cells, Blood, 91, 1216, 10.1182/blood.V91.4.1216 · DOI · Paper page
  40. Jacobs, 1999, Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF, Genes Dev., 13, 2678, 10.1101/gad.13.20.2678 · DOI · Paper page
  41. Pardal, 2005, Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors, Cold Spring Harb. Symp. Quant. Biol., 70, 177, 10.1101/sqb.2005.70.057 · DOI
  42. Takubo, 2013, Regulation of Glycolysis by Pdk Functions as a Metabolic Checkpoint for Cell Cycle Quiescence in Hematopoietic Stem Cells, Cell Stem Cell, 12, 49, 10.1016/j.stem.2012.10.011 · DOI · Paper page
  43. Harris, 2013, Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo, Blood, 121, 2483, 10.1182/blood-2012-12-471201 · DOI · Paper page
  44. Yu, 2013, Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation, Cell Stem Cell, 12, 62, 10.1016/j.stem.2012.11.022 · DOI · Paper page
  45. Harman, 1972, Free radical theory of aging: Dietary implications, Am. J. Clin. Nutr., 25, 839, 10.1093/ajcn/25.8.839 · DOI
  46. Jang, 2007, A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche, Blood, 110, 3056, 10.1182/blood-2007-05-087759 · DOI · Paper page
  47. Miyamoto, 2007, Foxo3a is essential for maintenance of the hematopoietic stem cell pool, Cell Stem Cell, 1, 101, 10.1016/j.stem.2007.02.001 · DOI · Paper page
  48. Yuan, 2012, SIRT1 is required for long-term growth of human mesenchymal stem cells, J. Mol. Med., 90, 389, 10.1007/s00109-011-0825-4 · DOI
  49. Chen, 2014, Role of SIRT1 and AMPK in mesenchymal stem cells differentiation, Ageing Res. Rev., 13, 55, 10.1016/j.arr.2013.12.002 · DOI
  50. Ren, 2017, Regulation of Stem Cell Aging by Metabolism and Epigenetics, Cell Metab., 26, 460, 10.1016/j.cmet.2017.07.019 · DOI · Paper page
  51. Tatar, 2016, Mitochondria: Masters of Epigenetics, Cell, 165, 1052, 10.1016/j.cell.2016.05.021 · DOI
  52. Berger, S.L., and Sassone-Corsi, P. (2016). Metabolic Signaling to Chromatin. Cold Spring Harb. Perspect. Biol., 8. · DOI
  53. Ahlqvist, 2012, Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice, Cell Metab., 15, 100, 10.1016/j.cmet.2011.11.012 · DOI · Paper page
  54. Cozzi, 2019, Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging, Stem Cell Rep., 13, 832, 10.1016/j.stemcr.2019.09.002 · DOI
  55. Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proc. Natl. Acad. Sci. USA, 98, 12072, 10.1073/pnas.211053698 · DOI · Paper page
  56. Rhinn, M., Ritschka, B., and Keyes, W.M. (2019). Cellular senescence in development, regeneration and disease. Development, 146. · DOI · Paper page
  57. Latreille, 2018, Small extracellular vesicles and their miRNA cargo are anti-apoptotic members of the senescence-associated secretory phenotype, Aging (Albany. Ny)., 10, 1103
  58. Ullah, 2020, Emerging role of stem cell-derived extracellular microRNAs in age-associated human diseases and in different therapies of longevity, Ageing Res. Rev., 57, 100979, 10.1016/j.arr.2019.100979 · DOI
  59. Kadota, 2018, Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases, Mol. Asp. Med., 60, 92, 10.1016/j.mam.2017.11.005 · DOI · Paper page
  60. Beltrami, 2003, Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration we have documented the existence of cycling ventricu- lar myocytes in the normal and pathologic adult mam, Cell, 114, 763, 10.1016/S0092-8674(03)00687-1 · DOI · Paper page
  61. Ellison, 2013, Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair, Cell, 154, 827, 10.1016/j.cell.2013.07.039 · DOI · Paper page
  62. Messina, 2004, Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart, Circ. Res., 95, 911, 10.1161/01.RES.0000147315.71699.51 · DOI · Paper page
  63. Vicinanza, 2017, Adult cardiac stem cells are multipotent and robustly myogenic: C-kit expression is necessary but not sufficient for their identification, Cell Death Differ., 24, 2101, 10.1038/cdd.2017.130 · DOI · Paper page
  64. Aquila, 2019, c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration, Cell Death Dis., 10, 436, 10.1038/s41419-019-1655-5 · DOI
  65. Gimmelli, 2016, Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury, Cell Death Dis., 7, e2317, 10.1038/cddis.2016.205 · DOI
  66. Scalise, M., Torella, M., Marino, F., Ravo, M., Giurato, G., Vicinanza, C., Cianflone, E., Mancuso, T., Aquila, I., and Salerno, L. (2020). Atrial myxomas arise from multipotent cardiac stem cells. Eur. Heart J. · DOI
  67. Vicinanza, 2018, Kitcre knock-in mice fail to fate-map cardiac stem cells, Nature, 555, E1, 10.1038/nature25771 · DOI
  68. Ellison, 2014, Absence of Evidence Is Not Evidence of Absence: Pitfalls of Cre Knock-Ins in the c-Kit Locus, Circ. Res., 115, 415, 10.1161/CIRCRESAHA.114.304676 · DOI
  69. Aquila, 2018, The use and abuse of Cre/Lox recombination to identify adult cardiomyocyte renewal rate and origin, Pharmacol. Res., 127, 116, 10.1016/j.phrs.2017.06.012 · DOI
  70. Marino, 2019, Role of c-Kit in Myocardial Regeneration and Aging, Front. Endocrinol. (Lausanne)., 10, 371, 10.3389/fendo.2019.00371 · DOI
  71. Molkentin, 2014, An emerging consensus on cardiac regeneration, Nat. Med., 20, 1386, 10.1038/nm.3764 · DOI · Paper page
  72. Molkentin, 2016, Most of the Dust Has Settled, Circ. Res., 118, 17, 10.1161/CIRCRESAHA.115.307934 · doi:10.1161/circresaha.115.307934
  73. Scalise, 2019, Heterogeneity of Adult Cardiac Stem Cells, Adv. Exp. Med. Biol., 1169, 141, 10.1007/978-3-030-24108-7_8 · DOI
  74. Smith, 2014, Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart, Nat. Protoc., 9, 1662, 10.1038/nprot.2014.113 · DOI
  75. Chimenti, I., Gaetani, R., Barile, L., Forte, E., Ionta, V., Angelini, F., Frati, G., Messina, E., and Giacomello, A. (2012). Isolation and Expansion of Adult Cardiac Stem/Progenitor Cells in the Form of Cardiospheres from Human Cardiac Biopsies and Murine Hearts, Humana Press. · DOI
  76. Bollini, 2014, Re-Activated Adult Epicardial Progenitor Cells Are a Heterogeneous Population Molecularly Distinct from Their Embryonic Counterparts, Stem Cells Dev., 23, 1719, 10.1089/scd.2014.0019 · DOI
  77. Smart, 2011, De novo cardiomyocytes from within the activated adult heart after injury, Nature, 474, 640, 10.1038/nature10188 · DOI · Paper page
  78. Martin, 2004, Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart, Dev. Biol., 265, 262, 10.1016/j.ydbio.2003.09.028 · DOI · Paper page
  79. Pfister, 2005, CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation, Circ. Res., 97, 52, 10.1161/01.RES.0000173297.53793.fa · DOI · Paper page
  80. Sandstedt, 2012, Left atrium of the human adult heart contains a population of side population cells, Basic Res. Cardiol., 107, 255, 10.1007/s00395-012-0255-7 · doi:10.1007/s00395-012-0255-7
  81. Oh, 2003, Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction, Proc. Natl. Acad. Sci. USA, 100, 12313, 10.1073/pnas.2132126100 · DOI · Paper page
  82. Roccio, 2008, Progenitor cells isolated from the human heart: A potential cell source for regenerative therapy, Neth. Heart J., 16, 163, 10.1007/BF03086138 · doi:10.1007/bf03086138
  83. Smits, 2009, Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: An in vitro model for studying human cardiac physiology and pathophysiology, Nat. Protoc., 4, 232, 10.1038/nprot.2008.229 · DOI · Paper page
  84. Laugwitz, 2005, Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages, Nature, 433, 647, 10.1038/nature03215 · DOI · Paper page
  85. Bu, 2009, Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages, Nature, 460, 113, 10.1038/nature08191 · DOI · Paper page
  86. Noseda, 2015, PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium, Nat. Commun., 6, 6930, 10.1038/ncomms7930 · DOI
  87. Cai, 2003, Isl1 Identifies a Cardiac Progenitor Population that Proliferates Prior to Differentiation and Contributes a Majority of Cells to the Heart, Dev. Cell, 5, 877, 10.1016/S1534-5807(03)00363-0 · DOI · Paper page
  88. Kanisicak, 2014, C-kit+ cells minimally contribute cardiomyocytes to the heart, Nature, 509, 337, 10.1038/nature13309 · DOI · Paper page
  89. Sultana, 2015, Resident c-kit+ cells in the heart are not cardiac stem cells, Nat. Commun., 6, 8701, 10.1038/ncomms9701 · DOI · Paper page
  90. Liu, 2016, Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes, Cell Res., 26, 119, 10.1038/cr.2015.143 · DOI · Paper page
  91. He, 2019, Reassessment of c-Kit+ Cells for Cardiomyocyte Contribution in Adult Heart, Circulation, 140, 164, 10.1161/CIRCULATIONAHA.119.039909 · doi:10.1161/circulationaha.119.039909
  92. Chien, 2019, Regenerating the field of cardiovascular cell therapy, Nat. Biotechnol., 37, 232, 10.1038/s41587-019-0042-1 · DOI · Paper page
  93. Epstein, 2019, A Time to Press Reset and Regenerate Cardiac Stem Cell Biology, Jama Cardiol., 4, 95, 10.1001/jamacardio.2018.4435 · doi:10.1001/jamacardio.2018.4435
  94. Cianflone, 2018, Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells, Cell Cycle., 17, 927, 10.1080/15384101.2018.1464852 · DOI
  95. Marotta, 2018, Combining cell and gene therapy to advance cardiac regeneration, Expert Opin Biol Ther., 18, 409, 10.1080/14712598.2018.1430762 · DOI
  96. Mancuso, T., Barone, A., Salatino, A., Molinaro, C., Marino, F., Scalise, M., Torella, M., De Angelis, A., Urbanek, K., and Torella, D. (2020). Unravelling the Biology of Adult Cardiac Stem Cell-Derived Exosomes to Foster Endogenous Cardiac Regeneration and Repair. Int J. Mol. Sci., 21. · DOI
  97. Cesselli, 2018, Cardiac stem cell aging and heart failure, Pharmacol. Res., 127, 26, 10.1016/j.phrs.2017.01.013 · DOI
  98. Avolio, 2014, Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction, Stem Cells, 32, 2373, 10.1002/stem.1728 · DOI
  99. Cesselli, 2011, Effects of age and heart failure on human cardiac stem cell function, Am. J. Pathol., 179, 349, 10.1016/j.ajpath.2011.03.036 · DOI · Paper page
  100. Gianfranceschi, 2016, Critical role of lysosomes in the dysfunction of human Cardiac Stem Cells obtained from failing hearts, Int. J. Cardiol., 216, 140, 10.1016/j.ijcard.2016.04.155 · DOI
  101. Urbanek, 2005, Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure, Proc. Natl. Acad. Sci. USA, 102, 8692, 10.1073/pnas.0500169102 · DOI · Paper page
  102. Hariharan, 2015, Nucleostemin Rejuvenates Cardiac Progenitor Cells and Antagonizes Myocardial Aging, J. Am. Coll. Cardiol., 65, 133, 10.1016/j.jacc.2014.09.086 · DOI
  103. Chong, 2011, Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin, Cell Stem Cell, 9, 527, 10.1016/j.stem.2011.10.002 · DOI · Paper page
  104. Farbehi, N., Patrick, R., Dorison, A., Xaymardan, M., Janbandhu, V., Wystub-Lis, K., Ho, J.W., Nordon, R.E., and Harvey, R.P. (2019). Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. Elife, 8. · DOI · Paper page
  105. Torella, 2014, Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy, J. Am. Heart Assoc., 3, e000434, 10.1161/JAHA.113.000434 · DOI · Paper page
  106. Torella, 2018, miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes, Diabetes, 67, 2554, 10.2337/db17-1434 · DOI
  107. Satthenapalli, 2017, Concise Review: Challenges in Regenerating the Diabetic Heart: A Comprehensive Review, Stem Cells, 35, 2009, 10.1002/stem.2661 · DOI
  108. Vecellio, 2014, The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients, Diabetes, 63, 2132, 10.2337/db13-0731 · DOI
  109. Nguyen, 2011, Impaired muscle regeneration in ob/ob and db/db mice, Sci. World J., 11, 1525, 10.1100/tsw.2011.137 · DOI
  110. She, 2012, Hyperglycemia suppresses cardiac stem cell homing to peri-infarcted myocardium via regulation of ERK1/2 and p38 MAPK activities, Int. J. Mol. Med., 30, 1313, 10.3892/ijmm.2012.1125 · DOI
  111. Saw, 2018, Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells, Cell Death Differ., 25, 1336, 10.1038/s41418-017-0047-6 · DOI
  112. Zhang, 2018, Hyperglycemia Altered the Fate of Cardiac Stem Cells to Adipogenesis through Inhibiting the β-Catenin/TCF-4 Pathway, Cell. Physiol. Biochem., 49, 2254, 10.1159/000493828 · DOI
  113. Cappetta, 2017, Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity, Oxid. Med. Cell. Longev., 2017, 1521020, 10.1155/2017/1521020 · DOI · Paper page
  114. Farías, J.G., Molina, V.M., Carrasco, R.A., Zepeda, A.B., Figueroa, E., Letelier, P., and Castillo, R.L. (2017). Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress. Nutrients, 9. · DOI · Paper page
  115. Ewer, 2010, Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction, J. Clin. Oncol., 28, 3901, 10.1200/JCO.2010.30.6274 · DOI
  116. Deidda, 2016, Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection, J. Cardiovasc. Med., 17, S76, 10.2459/JCM.0000000000000373 · doi:10.2459/jcm.0000000000000373
  117. Piegari, 2010, Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function, Circulation, 121, 276, 10.1161/CIRCULATIONAHA.109.895771 · DOI · Paper page
  118. Piegari, 2013, Doxorubicin induces senescence and impairs function of human cardiac progenitor cells, Basic Res. Cardiol., 108, 334, 10.1007/s00395-013-0334-4 · DOI · Paper page
  119. Piegari, 2015, SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells, Int. J. Cardiol., 189, 30, 10.1016/j.ijcard.2015.03.438 · DOI
  120. Piegari, 2016, MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat, Oncotarget, 7, 62312, 10.18632/oncotarget.11468 · DOI
  121. Lazzarini, 2016, The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity, Sci. Rep., 6, 29994, 10.1038/srep29994 · DOI
  122. Huang, 2010, Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice, Circulation, 121, 675, 10.1161/CIRCULATIONAHA.109.902221 · DOI · Paper page
  123. Carresi, 2018, Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kitposCD45negCD31neg cardiac stem cell activation, J. Mol. Cell. Cardiol., 119, 10, 10.1016/j.yjmcc.2018.04.007 · DOI
  124. Milano, 2020, Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity, Cardiovasc. Res., 116, 383
  125. Zhou, 2016, Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming, Cell Stem Cell, 18, 382, 10.1016/j.stem.2016.02.003 · DOI · Paper page

Cited by

See all 132

Metadata

Authors
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D.
Venue
Cells
Publisher
MDPI AG
Published
2020-06-26
Volume
9
Issue
6
Pages
1558
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3037810954
Cited by
132
References
121
FWCI
9.93
Type
journal article
Language
en
Open access
gold
Funders
  • Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN2015 2015ZTT5KB_004; 2017NKB2N4_005; RBFR12I3KA; PON03PE00009_2—iCARE)
  • Ministero della Salute (GR-2010-2318945)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.